We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,173 results
  1. Fibrogenesis

    Reference work entry 2024
  2. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction

    Current researches have confirmed that Smads, mediators of TGF-β signaling, are strictly controlled by domain-specific site phosphorylation in the...

    Juan Yang, Yongfang Gong, ... Yan Yang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 30 June 2021
  3. Collagen gene cluster expression and liver fibrogenesis in patients with biliary atresia: a preliminary study

    Objective

    Biliary atresia (BA) is a progressive fibro-obliterative disease of the biliary tract, which results in end-stage liver disease. However,...

    Gunadi, Dyah Ayu Puspitarani, ... Akhmad Makhmudi in BMC Research Notes
    Article Open access 01 December 2023
  4. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells

    UDP-glucose ceramide glucosyltransferase (UGCG) is the first key enzyme in glycosphingolipid (GSL) metabolism that produces glucosylceramide...

    Zi-bo Li, Lin Jiang, ... Cai-yan Wang in Acta Pharmacologica Sinica
    Article 10 January 2023
  5. Transcriptional regulation of Glis2 in hepatic fibrosis

    The role of Gli-similar 2 (Glis2) in hepatic fibrosis (HF) is controversial. In this study, we focused on the functional and molecular mechanisms...

    Huan-Yu Gong, Peng-Cheng Zhou, ... Zhen-Guo Liu in Experimental & Molecular Medicine
    Article Open access 03 July 2023
  6. TGF-β signaling: critical nexus of fibrogenesis and cancer

    The transforming growth factor-beta (TGF-β) signaling pathway is a vital regulator of cell proliferation, differentiation, apoptosis, and...

    Anna O. Giarratana, Conor M. Prendergast, ... Kathleen M. Capaccione in Journal of Translational Medicine
    Article Open access 26 June 2024
  7. Hepatic HRC induces hepatocyte pyroptosis and HSCs activation via NLRP3/caspase-1 pathway

    The histidine-rich calcium-binding protein (HRC) is a regulator of Ca2 + homeostasis and it plays a significant role in liver fibrosis. Pyroptosis, a...

    **gwen Wu, Mingyu Zhang, ... **gmei Liu in Journal of Molecular Medicine
    Article 12 November 2022
  8. Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability

    Background

    Liver fibrosis is a wound-healing response to chronic injury, featuring with excess accumulation of extracellular matrix secreted by the...

    **ao-Mei Yang, Zheng Wu, ... Xueyun Ma in BMC Pharmacology and Toxicology
    Article Open access 22 July 2022
  9. Effects of Bulleyaconitine A on Extracellular Matrix Secretion and Expression of Related Proteins in Acetaldehyde-Activated Hepatic Stellate Cells

    Activated hepatic stellate cells differentiate into myofibroblasts, which synthesize and secrete extracellular matrix (ECM) leading to liver...

    Q. W. Song, Y. P. Yuan, ... X. N. Tang in Bulletin of Experimental Biology and Medicine
    Article 02 July 2024
  10. Characterization of focal adhesion proteins in rodent hepatic stellate cells

    Ongoing liver injury leads to fibrosis and ultimately cirrhosis, a leading cause of death worldwide. The primary mechanism underlying the fibrogenic...

    Nour Hijazi, Zengdun Shi, Don C. Rockey in Histochemistry and Cell Biology
    Article 12 August 2022
  11. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment

    Hepatic fibrosis/cirrhosis is a significant health burden worldwide, resulting in liver failure or hepatocellular carcinoma (HCC) and accounting for...

    Xue Yang, Qing Li, ... Zhipeng Han in Cellular & Molecular Immunology
    Article 24 February 2023
  12. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation

    Liver fibrosis is one of the most severe pathologic consequences of chronic liver diseases, and effective therapeutic strategies are urgently needed....

    Zhen-ning Lu, Wei-xiao Niu, ... Hong-wei He in Acta Pharmacologica Sinica
    Article 31 August 2021
  13. Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice

    Background and aims

    Kinin B1 receptors (B1Rs) are implicated in the pathogenesis of fibrosis. This study examined the anti-fibrotic effects of B1R...

    Dileep Reddy Rampa, Huiying Feng, ... Dongmei Wu in Journal of Translational Medicine
    Article Open access 13 December 2022
  14. Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis

    Background

    Extracellular vesicles derived from mesenchymal stem/stromal cells (MSCs) have shown therapeutic effects on liver fibrosis. This study...

    Wenjie Zheng, Saiyan Bian, ... Weixin Zhao in Inflammation and Regeneration
    Article Open access 05 October 2023
  15. Eicosapentaenoic acid loaded silica nanoemulsion attenuates hepatic inflammation through the enhancement of cell membrane components

    Background

    Liver inflammation is a multistep process that is linked with cell membrane fatty acids composition. The effectiveness of eicosapentaenoic...

    Jihan Hussein, Mona A. El-Bana, ... Dalia Medhat in Biological Procedures Online
    Article Open access 07 September 2022
  16. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells

    Background

    Schistosomiasis is a serious but neglected parasitic disease in humans that may lead to liver fibrosis and death. Activated hepatic...

    Hongyan Kong, Qiqin Song, ... Jiaquan Huang in Parasites & Vectors
    Article Open access 06 June 2023
  17. The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends

    Acid sphingomyelinase (ASMase) serves as one of the most remarkable enzymes in sphingolipid biology. ASMase facilitates the hydrolysis of...

    Ishfaq Hassan Mir, Chinnasamy Thirunavukkarasu in Archives of Toxicology
    Article 29 May 2023
  18. Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro

    Background

    The transformation of hepatic stellate cell (HSC) to myofibroblast is a key event during liver fibrogenesis. However, the differentiation...

    Hua Wang, Shao** Zheng, ... Zhihong Weng in Journal of Translational Medicine
    Article Open access 29 January 2022
  19. Metabolomics reveals that chronic restraint stress alleviates carbon tetrachloride-induced hepatic fibrosis through the INSR/PI3K/AKT/AMPK pathway

    Abstract

    Hepatic fibrosis (HF) could be developed into liver cirrhosis or even hepatocellular carcinoma. Stress has an important role in the...

    Shanshan Zhang, Binjie Liu, ... Zhongqiu Liu in Journal of Molecular Medicine
    Article 23 November 2023
  20. Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats

    Background

    Mesenchymal stem cells (MSCs) are multipotent stromal cells and could exert hepatoprotective effects against acute liver injury,...

    Masateru Nomura, Joseph George, ... Mikihiro Tsutsumi in Molecular Medicine
    Article Open access 29 November 2022
Did you find what you were looking for? Share feedback.